MSL
BSX.PRA

Mackay Shields LLC’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Mackay Shields LLC’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$411K Hold
2022
Q4 		$391K Hold
2022
Q3 		$349K Sell
2022
Q2 		$348K Buy
2022
Q1 		$396K Hold
2021
Q4 		$388K Buy
2020
Q4 		– Sell
2020
Q3 		$379K Buy